What is VKTX's current stock price?

As of now, VKTX is trading at $38.55, with a daily change of -0.05%.

Market Overview Trending Stocks Stock Screener Trade Insights

Top Rated Stocks Most Active Stocks Top Potential Stocks Top Momentum Stocks Leaderboard

About Us Log In Sign Up Plans & Pricing Contact Us Terms of Use Privacy Policy

Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist

VKTX Stock Analysis & IQ Rating | Viking Therapeutics

VKTX

Viking Therapeutics

$38.55

-$0.02 | -0.05%

Create Alerts

Overview

Comments

Insights

Risks

Rating

Chart

Analysts

Street

Sentiment

Headlines

52W High

$51.92

MKT CAP

$4.36B

52W Low

$18.92

VOL

$2.73M

P/E Ratio

N/A

AVG VOL

$4.03M

RSI

58.90

TREND

Uptrend

VKTX Stock IQ

Login to see Viking Therapeutics (VKTX) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid

VKTX Target Price

Login to display

Strengths

VKTX Rewards

Upgraded on attractively valued

VKTX Rewards

Earnings are forecast to grow

VKTX Rewards

Investors confidence is positive

VKTX Price Performance

$36.77 (+4.84%)

$25.74 (+49.77%)

$31.63 (+21.88%)

$38.28 (+0.71%)

1year

6month

3month

1month

VKTX Risk Level

VKTX has Low risk level based on volatility, sector strength, volume, investor confidence, and outlook.

Click here to check what is your level of risk

Risks Indicators

High volatilty

Low

LOW

HIGH

VKTX Analysts Opinion

VKTX overall standing based on key factors, offering insights into analysts perspectives and market expectations.
menu Hover over the category for more information

VKTX Analysts Opinion

VKTX Analysts opinion is positive and also has improved from the past 3 months

VKTX Street Sentiment

Analysts perspectives on the stock desirability, trend direction, and growth potential

92%

Buy
Opinion

Trend
Score

Potential
Score

Consensus Rating

100%

50%

100%

VKTX Street Sentiment

VKTX Street Sentiment is extremely bullish and have positive views on the near-term outlook

VKTX Performance Sentiment

Sentiments overview associated with VKTX events and the stock performance.

92%

8%

Positive

Negative

11 out of 12
events present

1 out of 12
events present

Very Bullish

Bullish

Neutral

Bearish

Very Bearish

Technical Price Levels

Average key support and resistance price levels

Login to display

Support
Price

$35.41

Resistance
Price

$32.52

Current Price Range

$40.78

Show methods +

Linked to VKTX

IQ

Close Price

Change

MRK

4.03

99.72

-1.16%

LLY

4.13

1010.31

-0.41%

GPCR

2.00

34.56

+5.21%

EBS

2.43

11.90

-1.24%

TVTX

3.50

35.00

-0.93%

VKTX Latest Analysis +

Whats Up With The Jump In Viking Therapeutics Stock?. ) .VKTX stock is racing ahead of the pack. Viking disclosed toward the end of November that it had completed the patient enrollment for subcutaneous VK2735 in its Phase 3 VANQUISH-1 clinical trial ahead of schedule which was a positive surprise for investors. The firm was able to attract nearly 4650 adults who were either obese or overweight and impacted by at least one condition associated with their weight which was larger than the target s

Thu Dec 4, 2025

$38.57 | +8.92%

Rating

VKTX Stock Rises 34% in Three Months: Heres What You Should Know. Viking Therapeutics shares jump 34% as rapid VK2735 trial enrollment boosts optimism amid intensifying interest in obesity treatments.

Mon Dec 1, 2025

$34.55 | -6.14%

Momentum

Wall Street Analysts Think Viking Therapeutics (VKTX) Is a Good Investment: Is It?. According to the average brokerage recommendation (ABR) one should invest in Viking Therapeutics (VKTX). It is debatable whether this highly sought-after metric is effective because Wall Street analysts recommendations tend to be overly optimistic. Would it be worth investing in the stock?

Fri Nov 28, 2025

$36.81 | +1.49%

Potential

Viking Therapeutics to Participate at the Piper Sandler 37th Annual Healthcare Conference. ) a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders today announced that it will participate at the Piper Sandler 37th Annual Healthcare Conference. The conference will take place ...

Tue Nov 25, 2025

$35.46 | +2.34%

Activity

VKTX Completes Enrollment in First Late-Stage Study on Obesity Drug. Viking Therapeutics completes enrollment in its phase III VANQUISH-1 obesity study surpassing targets and marking rapid progress for its VK2735 program.

Thu Nov 20, 2025

$34.27 | -5.05%

Activity

Viking Therapeutics Up 62% Since August Undercuts A Buy Zone Despite Key Win. Viking Therapeutics stock fell Wednesday after the company said it overenrolled one of its final-phase studies for its weight-loss shot.The post Viking Therapeutics Up 62% Since August Undercuts A Buy Zone Despite Key Win appeared first on Investor'.s Business Daily.

Wed Nov 19, 2025

$36.04 | -4.56%

Momentum

Viking Therapeutics Announces Completion of Enrollment in Phase 3 VANQUISH-1 Trial of VK2735. 78-Week Study Evaluating Subcutaneous VK2735 in Adults with ObesityEnrollment Completed Ahead of Schedule and Above Target Size Indicating Strong Interest in VK2735) a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders today announced the completion of patient enrollment in its Phase 3 VANQUISH-1 clinical trial of subcutaneous VK2

Wed Nov 19, 2025

$36.04 | -4.56%

Activity

Potential

Rating

Viking Therapeutics Inc. (VKTX) Presents at Jefferies London Healthcare Conference 2025 Transcript.

Wed Nov 19, 2025

$36.04 | -4.56%

Activity

FAQ About VKTX Stock Insights

What is VKTX current stock price?

What are VKTX stock strengths?

What is VKTX Risk Level?

What is VKTX market cap and volume?

What is VKTX current Stock IQ?

Should I buy VKTX stock right now?

Is VKTX a Strong Buy right now?

What does a 'Strong Buy' rating mean for VKTX?

What does a 'Strong Sell' rating mean for VKTX?

What factors influence VKTX's Stock IQ?

Explore our VKTX Stock insights

In-Depth Market Analysis and Trends
Expert Insights on Market Dynamics
Tailored VKTX Stock Strategies
Effective Risk Management

FIND US ON

Receive our VKTX Daily Alerts

Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts

Market Trends

Stay ahead of the market

Market trends

Investment tips

Market analysis service

Investment Insights

Future potential

Informed investment decisions

Investment analysis

IInvestment strategies

Stock Analysis

In-depth stock analysis

Performance analysis

Stock market insights

Financial trends analysis

VKTX

Viking Therapeutics

Current Price

$38.55

-$0.02 | -0.05%

52W High

$51.92

MKT CAP

$4.36B

52W Low

$18.92

VOL

$2.73M

P/E Ratio

N/A

AVG VOL

$4.03M

RSI

58.90

TREND

Uptrend

Create Alerts

Overview

Comments

Insights

Risks

Rating

Chart

Analysts

Street

Sentiment

Target Price

Login to display

Not Enough Information

Stock Insights

Strengths

VKTX Rewards

Upgraded on attractively valued

VKTX Rewards

Earnings are forecast to grow

VKTX Rewards

Investors confidence is positive

Linked to VKTX

Symbol

IQ

Close

Change

MRK

4.03

99.72

-1.16%

LLY

4.13

1010.31

-0.41%

GPCR

2.00

34.56

+5.21%

EBS

2.43

11.90

-1.24%

TVTX

3.50

35.00

-0.93%

VKTX Price Performance

$36.77 (+4.84%)

$25.74 (+49.77%)

$31.63 (+21.88%)

$38.28 (+0.71%)

1year

6month

3month

1month

VKTX Analysts Opinion

VKTX Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
menu Hover over the category for more information

VKTX Analysts Opinion

VKTX Analysts opinion is positive and also has improved from the past 3 months

VKTX Street Sentiment

Analysts perspectives on the stock desirability, trend direction, and growth potential

92%

Buy
Opinion

Trend
Score

Potential
Score

Consensus Rating

100%

50%

100%

VKTX Street Sentiment

VKTX Street Sentiment is extremely bullish and have positive views on the near-term outlook

VKTX Risk Level

VKTX has Low risk level based on volatility, sector strength, volume, investor confidence, and outlook.

Click here to check what is your level of risk

Risks Indicators

High volatilty

Low

LOW

HIGH

VKTX Performance Sentiment

Sentiments overview associated with VKTX events and the stock performance.

92%

8%

Positive

Negative

11 out of 12
events present

1 out of 12
events present

Very Bullish

Bullish

Neutral

Bearish

Very Bearish

Technical Price Levels

Average key support and resistance price levels

Login to display

Support
Price

$35.41

Resistance
Price

$32.52

Current Price Range

$40.78

Show methods +

VKTX Stock IQ

Login to unlock Viking Therapeutics (VKTX) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid

VKTX Latest Analysis

Whats Up With The Jump In Viking Therapeutics Stock?. ) .VKTX stock is racing ahead of the pack. Viking disclosed toward the end of November that it had completed the patient enrollment for subcutaneous VK2735 in its Phase 3 VANQUISH-1 clinical trial ahead of schedule which was a positive surprise for investors. The firm was able to attract nearly 4650 adults who were either obese or overweight and impacted by at least one condition associated with their weight which was larger than the target s

Thu Dec 4, 2025

$38.57 | +8.92%

Rating

VKTX Stock Rises 34% in Three Months: Heres What You Should Know. Viking Therapeutics shares jump 34% as rapid VK2735 trial enrollment boosts optimism amid intensifying interest in obesity treatments.

Mon Dec 1, 2025

$34.55 | -6.14%

Momentum

Wall Street Analysts Think Viking Therapeutics (VKTX) Is a Good Investment: Is It?. According to the average brokerage recommendation (ABR) one should invest in Viking Therapeutics (VKTX). It is debatable whether this highly sought-after metric is effective because Wall Street analysts recommendations tend to be overly optimistic. Would it be worth investing in the stock?

Fri Nov 28, 2025

$36.81 | +1.49%

Potential

Viking Therapeutics to Participate at the Piper Sandler 37th Annual Healthcare Conference. ) a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders today announced that it will participate at the Piper Sandler 37th Annual Healthcare Conference. The conference will take place ...

Tue Nov 25, 2025

$35.46 | +2.34%

Activity

VKTX Completes Enrollment in First Late-Stage Study on Obesity Drug. Viking Therapeutics completes enrollment in its phase III VANQUISH-1 obesity study surpassing targets and marking rapid progress for its VK2735 program.

Thu Nov 20, 2025

$34.27 | -5.05%

Activity

Viking Therapeutics Up 62% Since August Undercuts A Buy Zone Despite Key Win. Viking Therapeutics stock fell Wednesday after the company said it overenrolled one of its final-phase studies for its weight-loss shot.The post Viking Therapeutics Up 62% Since August Undercuts A Buy Zone Despite Key Win appeared first on Investor'.s Business Daily.

Wed Nov 19, 2025

$36.04 | -4.56%

Momentum

Viking Therapeutics Announces Completion of Enrollment in Phase 3 VANQUISH-1 Trial of VK2735. 78-Week Study Evaluating Subcutaneous VK2735 in Adults with ObesityEnrollment Completed Ahead of Schedule and Above Target Size Indicating Strong Interest in VK2735) a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders today announced the completion of patient enrollment in its Phase 3 VANQUISH-1 clinical trial of subcutaneous VK2

Wed Nov 19, 2025

$36.04 | -4.56%

Activity

Potential

Rating

Viking Therapeutics Inc. (VKTX) Presents at Jefferies London Healthcare Conference 2025 Transcript.

Wed Nov 19, 2025

$36.04 | -4.56%

Activity

Discover VKTX Stock analysis and effective trading strategies with StocksRunner.com. Gain valuable insights into stock performance, market trends, and the future potential of VKTX. We're here to help you make informed investment decisions today.

FIND US ON

Receive our VKTX Daily Alerts

Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts

Market trends

In-depth stock analysis

Informed investment decisions

Stock market insights

Stock trading tips

Stock analysis

VKTX Stock trends

VKTX Stock performance

VKTX Stock analysis

VKTX investment strategies

Stock strategies

Trading strategies

StocksRunner updates

StocksRunner Insights

Financial Reports

Disclaimer: Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor. The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses. Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.

Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").

This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.

✕

Don't Be a Sheep, Be a StocksRunner

StocksRunner Aggregates The Most Important Headlines Into A Single Stock IQ

Sign up for free and

continue analysing VKTX

Signup to Stocksrunner

Already a Member? Click here to Login

Join us on this journey to revolutionize the way you approach investing. Together, let's navigate the stock market with clarity, confidence, and cutting-edge intelligence.

✕

Don't Be a Sheep, Be a StocksRunner

StocksRunner Aggregates The Most Important Headlines Into A Single Stock IQ

Sign up for free and

continue analysing VKTX

Signup to Stocksrunner

Already a Member? Click here to Login

Join us on this journey to revolutionize the way you approach investing. Together, let's navigate the stock market with clarity, confidence, and cutting-edge intelligence.

VKTX Stock Analysis & IQ Rating | Viking Therapeutics

VKTX Stock IQ

VKTX Target Price

VKTX Risk Level

VKTX Analysts Opinion

VKTX Street Sentiment

VKTX Performance Sentiment

Technical Price Levels

Explore our VKTX Stock insights

Receive our VKTX Daily Alerts

VKTX Street Sentiment

VKTX Risk Level

Technical Price Levels

Discover VKTX Stock analysis and effective trading strategies with StocksRunner.com. Gain valuable insights into stock performance, market trends, and the future potential of VKTX. We're here to help you make informed investment decisions today.

Receive our VKTX Daily Alerts

VKTX Runner Alarm